EARNINGS: Safestay annual loss widens; Wynnstay ups interim dividend
(Alliance News) - The following is a round-up of earnings of London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 0.35p on 21-07-2026 at 15:30:01 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.40p |
| Sell | 0.30p |
| Last Trade: | Buy 1,838.00 at 0.40p |
| Day's Volume: | 26,037 |
| Last Close: | 0.35p |
| Open: | 0.35p |
| ISIN: | GB00BM8HZD43 |
| Day's Range | 0.35p - 0.35p |
| 52wk Range: | 0.325p - 0.95p |
| Market Capitalisation: | £8.01m |
| VWAP: | 0.359988p |
| Shares in Issue: | 2.29b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Verici Dx (VRCI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,838 | 0.40p | Ordinary |
13:35:56 - 21-Jul-26 |
| Sell* | 2,477 | 0.30p | Ordinary |
13:35:39 - 21-Jul-26 |
| Buy* | 2,571 | 0.40p | Ordinary |
13:35:23 - 21-Jul-26 |
| Sell* | 2,501 | 0.30p | Ordinary |
09:58:36 - 21-Jul-26 |
| Buy* | 10,182 | 0.40p | Ordinary |
08:58:50 - 21-Jul-26 |
| Buy* | 1,028 | 0.40p | Ordinary |
08:43:42 - 21-Jul-26 |
| Sell* | 5,440 | 0.30p | Ordinary |
08:02:27 - 21-Jul-26 |
| Buy* | 1 | 0.37p | Ordinary |
16:22:42 - 20-Jul-26 |
| Buy* | 1 | 0.37p | Ordinary |
15:58:43 - 20-Jul-26 |
| Sell* | 141,930 | 0.347p | Ordinary |
15:09:28 - 20-Jul-26 |
Verici Dx (VRCI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Jul 2026 7:00 am | RNS-R | Investor presentation |
| 1st Jul 2026 11:22 am | RNS | Holding(s) in Company |
| 29th Jun 2026 7:00 am | RNS | Final results for the year ended 31 December 2025 |
| 25th Jun 2026 4:08 pm | RNS | Holding(s) in Company |
| 24th Jun 2026 5:24 pm | RNS | Holding(s) in Company |
| 24th Jun 2026 4:34 pm | RNS | Holding(s) in Company |
| 24th Jun 2026 12:37 pm | RNS | Holding(s) in Company |
| 24th Jun 2026 11:13 am | RNS | Holding(s) in Company |
| 24th Jun 2026 9:06 am | RNS | Holding(s) in Company |
| 24th Jun 2026 7:00 am | RNS | New York State clinical lab certification received |